May 28, 2021
The Ministry of Health, Labor and Welfare (MHLW) on May 27 approved AbbVie’s rheumatoid arthritis (RA) drug Rinvoq (upadacitinib) for the treatment of psoriatic arthritis, making it the first JAK inhibitor carrying a psoriasis indication in Japan. Rinvoq was first...read more